|Antiretroviral therapy for prevention of tuberculosis in adults with HIV: a systematic review and meta-analysis|
AB Suthar, SD Lawn, J Del Amo, H Getahun, C Dye, D Sculier, ...
PLoS Med 9 (7), e1001270, 2012
|Towards universal voluntary HIV testing and counselling: a systematic review and meta-analysis of community-based approaches|
AB Suthar, N Ford, PJ Bachanas, VJ Wong, JS Rajan, AK Saltzman, ...
PLoS Med 10 (8), e1001496, 2013
|Interventions to improve adherence to antiretroviral therapy: a rapid systematic review|
KH Chaiyachati, O Ogbuoji, M Price, AB Suthar, EK Negussie, ...
Aids 28, S187-S204, 2014
|Antiretroviral therapy in prevention of HIV and TB: update on current research efforts|
R Granich, S Gupta, A B Suthar, C Smyth, D Hoos, M Vitoria, M Simao, ...
Current HIV research 9 (6), 446-469, 2011
|The potential impact of expanding antiretroviral therapy and combination prevention in Vietnam: towards elimination of HIV transmission|
M Kato, R Granich, DD Bui, HV Tran, P Nadol, D Jacka, K Sabin, ...
Journal of acquired immune deficiency syndromes (1999) 63 (5), e142, 2013
|Effect of cotrimoxazole on mortality in HIV-infected adults on antiretroviral therapy: a systematic review and meta-analysis|
AB Suthar, R Granich, J Mermin, A Van Rie
Bulletin of the World Health Organization 90, 128-138, 2012
|Integrating antiretroviral therapy into antenatal care and maternal and child health settings: a systematic review and meta-analysis|
AB Suthar, D Hoos, A Beqiri, K Lorenz-Dehne, C McClure, C Duncombe
Bulletin of the World Health Organization 91, 46-56, 2013
|Improving antiretroviral therapy scale-up and effectiveness through service integration and decentralization|
AB Suthar, GW Rutherford, T Horvath, MC Doherty, EK Negussie
Aids 28, S175-S185, 2014
|Co-trimoxazole prophylaxis in adults, including pregnant women, with HIV: a systematic review and meta-analysis|
AB Suthar, MA Vitoria, JM Nagata, X Anglaret, D Mbori-Ngacha, O Sued, ...
The lancet HIV 2 (4), e137-e150, 2015
|A public health approach to hepatitis C control in low-and middle-income countries|
AB Suthar, AD Harries
PLoS Med 12 (3), e1001795, 2015
|Protease inhibitor-containing antiretroviral treatment and tuberculosis: can rifabutin fill the breach?|
A Loeliger, AB Suthar, D Ripin, P Glaziou, M O'Brien, F Renaud-Thery, ...
The International journal of tuberculosis and lung disease 16 (1), 6-15, 2012
|Global policy review of antiretroviral therapy eligibility criteria for treatment and prevention of HIV and tuberculosis in adults, pregnant women, and serodiscordant couples|
S Gupta, R Granich, AB Suthar, C Smyth, R Baggaley, D Sculier, A Date, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 62 (3), e87-e97, 2013
|Programmatic implications of acute and early HIV infection|
AB Suthar, RM Granich, M Kato, S Nsanzimana, JSG Montaner, ...
The Journal of infectious diseases 212 (9), 1351-1360, 2015
|Lessons learnt from implementation of the International Health Regulations: a systematic review|
AB Suthar, LG Allen, S Cifuentes, C Dye, JM Nagata
Bulletin of the World Health Organization 96 (2), 110, 2018
|Ending tuberculosis by 2030: can we do it?|
AB Suthar, R Zachariah, AD Harries
The international journal of tuberculosis and lung disease 20 (9), 1148-1154, 2016
|Enhancing the benefits of antiretroviral therapy in Vietnam: towards ending AIDS|
M Kato, NH Long, BD Duong, TT Van Nguyen, NH Hai, NT Van, ...
Current Hiv/aids Reports 11 (4), 487-495, 2014
|Benefits of combined preventive therapy with co-trimoxazole and isoniazid in adults living with HIV: time to consider a fixed-dose, single tablet coformulation|
AD Harries, SD Lawn, AB Suthar, R Granich
The Lancet Infectious Diseases 15 (12), 1492-1496, 2015
|Performance-based financing for improving HIV/AIDS service delivery: a systematic review|
AB Suthar, JM Nagata, S Nsanzimana, T Bärnighausen, EK Negussie, ...
BMC health services research 17 (1), 6, 2017
|Household survey of HIV incidence in Rwanda: a national observational cohort study|
S Nsanzimana, E Remera, S Kanters, A Mulindabigwi, AB Suthar, ...
The Lancet HIV 4 (10), e457-e464, 2017
|Ending the HIV/AIDS epidemic in low-and middle-income countries by 2030: is it possible?|
AD Harries, AB Suthar, KC Takarinda, H Tweya, NTT Kyaw, ...
F1000Research 5, 2016